
We fund academic centres at IIT, and work long-term for creating impact: Rahul Mehta, founder, Mehta Family Foundation
Established in 1996 and headquartered in Texas, USA, the Bhupat and Jyoti Mehta Family Foundation was established by Rahul and his siblings in memory of their parents.
The foundation has set up centres or schools at various IITs. Among them are the School of Biosciences at IIT Madras, Centre for Engineering in Medicine at IIT Kanpur, the School of Data Science and Artificial Intelligence at IIT Guwahati, the School of Health Sciences and Technology at IIT Guwahati, the School of Data Science & Artificial Intelligence at IIT Palakkad and IIT Roorkee. They have also recently launched the School of Sustainability and the School of Biosciences and Biomedical Engineering at IIT Indore.
MFF works with IITs in the areas of infrastructure, curriculum, professorships, conferences, joint research projects, faculty visits, and scholarship programmes. They also work on building collaboration between their schools at IIT and international universities.
Rahul spoke to indianexpress.com on MFF's journey, the opportunities for growth of IITs, his experiences working with them, and the way forward for Indian research and innovation. Edited excerpts:
Venkatesh Kannaiah: Could you tell us about yourself and the foundation?
Rahul Mehta: I was born in Bombay and moved to the United States at a very young age. I was the first in our family to pursue higher education overseas in the US, and the experience was transformative. Over the years, I founded and built four software startups. These ventures gave me not only financial independence but also a sense of responsibility to give back to society.
I established the foundation to honour my parents, and it is a family endeavour; my brothers and sisters are deeply involved, and we operate from Houston, Texas. Our mission is to create opportunities through education and innovation, particularly in areas that can drive long-term societal impact.
Venkatesh Kannaiah: Tell us about your work with IITs in India, and what is different about your collaboration with them?
Rahul Mehta: Our engagement with IITs began with a vision to address gaps in India's higher education, and our first initiative was funding a project at IIT Madras. At the time, India was already a powerhouse in computer science, producing global giants like Infosys and TCS. However, I saw a significant disparity when comparing Indian academia to its American counterparts. In the US, particularly in the early 2000s, about 50 per cent of academic research was focused on biological sciences; fields like biotechnology, bioinformatics, and bioengineering. In contrast, most IITs were heavily skewed toward computer science and traditional engineering disciplines, with little emphasis on biology-related programmes.
This led to the creation of the School of Bioscience and Bioengineering at IIT Madras in February 2006. Our goal was to introduce a curriculum that exposed Indian students to the engineering aspects of biology. It was a pioneering effort — the first programme of its kind at an IIT.
What makes our approach unique is our focus on impact over mere financial contribution.
To achieve our goals, we don't just fund projects; we actively shape them. We work closely with IITs to design curricula, bring in global expertise, and foster collaborations that elevate the quality of education and research. That is the core of our model — active engagement to maximise impact.
Venkatesh Kannaiah: How is your approach different from a typical philanthropy model?
Rahul Mehta: Our approach is not the 'write a cheque and walk away' model. It is about getting deeply involved in the process. When we fund a programme, it's not a one-off transaction; it is a commitment to ensure that the centre is impactful.
To build a world-class academic centre, you need more than just funding. You need a curriculum that reflects global standards, good faculty, and opportunities for students to engage with cutting-edge research. We facilitate all of this. For instance, we have a team of advisors/experts from institutions like Purdue and UC San Diego, who help design curricula. We also organise conferences and workshops, bringing together Indian and international academics to share knowledge and spark innovation.
We funded the School of Bioscience and Bioengineering at IIT Madras in 2006, and even after more than 20 years, our relationship remains strong. They regularly consult us, invite us to participate in their planning, and involve us in their initiatives.
Venkatesh Kannaiah: Why IITs and why these themes?
Rahul Mehta: The decision to focus on IITs stemmed from personal familiarity and their reputation. My sister graduated from an IIT, which gave me early exposure to them. IITs attract India's brightest students and some of the best undergraduate talent in the world.
Our initial focus was on biosciences and bioengineering, later followed by a Center for Engineering in Medicine at IIT Kanpur and the School of Health Science and Technology at IIT Guwahati.
In 2017, we recognised artificial intelligence (AI) as the next frontier. I wrote a paper urging IITs to prioritise AI, as it was becoming a transformative force globally. At the time, AI was not as mainstream as it is now. ChatGPT's release in 2022 brought it into the spotlight, but we saw its potential early. We funded AI schools at IIT Guwahati, Roorkee, and Palakkad, focusing on domain-specific applications like AI in healthcare, material science, and chemical engineering.
The third pillar of our strategy is sustainability. India faces significant environmental challenges, such as maintaining food security in the face of climate change. Biosciences, AI, and sustainability are interconnected fields that, when combined, can produce groundbreaking innovations.
Venkatesh Kannaiah: What have been your learnings from your collaboration with the IITs?
Rahul Mehta: While the quality of IIT undergraduates is good, the challenge is to expose them to cutting-edge technologies and global perspectives. Second, we have learned that Indian research needs to evolve. While India produces many PhDs, the focus should shift toward interdisciplinary, globally collaborative research that drives innovation.
We have a team of advisors through our MFF CARE Initiative — Collaborative for Academic Research and Excellence, where we tap into a network of thousands of Indian-origin professors in the US who are eager to contribute to India. Our foundation facilitates these collaborations, connecting Indian academics with global experts.
Venkatesh Kannaiah: Can you give us some idea of the number of students who have graduated from your centres?
Rahul Mehta: Across all our programmes, we have created capacity for 3,000 students, including 1,500 BTech and 1,500 Master's and PhD students. This is significant, as our efforts have added more capacity than some newer IITs, like Palakkad or Tirupati, which have around 1,800 students. Over the past five years, approximately 10,000 students have graduated, with 2,500 BTechs and over 3,000 currently enrolled. That's the kind of scale we are talking about.
Money is just one input. The time, energy, and expertise we invest in curriculum design, faculty support, and global collaborations are critical.
Venkatesh Kannaiah: Tell us about what needs to change in the IITs.
Rahul Mehta: IITs are doing a lot of things right; they attract good talent and produce graduates who excel globally. But to compete on the world stage, India needs to scale up. First, they need to increase capacity at each location from 2,000 students to 10,000 or more. Second, they need better leadership training and succession planning for directors, deans, and faculty. Some faculty should have the option to pursue administrative careers, as is the case in Western universities.
Third, the research ecosystem needs to be more multidisciplinary and collaborative. Currently, Indian faculty often find it easier to collaborate internationally than within India. We need to foster a culture of teamwork across disciplines and institutions.
Venkatesh Kannaiah: Can you tell us about any interesting tech innovations or interventions that have come out of your collaboration with IITs?
Rahul Mehta: One standout example is the cancer biobank at IIT Madras, one of India's first. It collects tissue samples from local hospitals to study differences between Indian and Western cancers, addressing the unique Indian genome. This is critical because most drugs are tested on Western populations, and we need to understand how they work for Indians.
At IIT Madras, researchers have created models to help doctors figure out how old a baby is inside the womb during pregnancy. This is helpful as about half of pregnant women in India miss their first checkup. These models are designed specifically for an Indian context and are now being used in hospitals in Tamil Nadu and at army hospitals.
At IIT Madras, researchers have created a special reference genome, like a genetic map, using DNA from 10,000 healthy people across 83 different groups in India. They used this to build a genomegraph, which helps make custom genetic maps for different Indian communities. This project is a digital public good, and it is freely available to help doctors and researchers find India-specific disease patterns.
We are also working on a Bharat Cancer Genome Atlas, and we plan to host India-specific cancer genomic data for various cancers prevalent in India.
At IIT Kanpur, our Centre is making progress in prostate cancer research, with results that could lead to new treatments. We have developed patented solutions for cancers, blood disorders, and neurodegenerative disorders and are partnering with companies to bring these innovations to the market.
Researchers have invented a special kind of insulin that stays stable even at high temperatures. This discovery of thermostable insulin has led to several research papers and patents. We have also developed a Brain-Machine Interface for restoring hand movements in patients paralysed by stroke, in collaboration with NIMHANS Bengaluru.
At IIT Roorkee, we have been focusing on innovative, AI-driven, urban mobility transportation solutions and have successfully launched a few products. Researchers at the centre have also developed a new method called Zero-Shot Knowledge Distillation (ZSKD), which is an easier way to make smaller, faster machine learning models without needing the original training data, which is often kept private or secret for safety or business reasons. This groundbreaking method has found a mention in over 300 research papers.
Venkatesh Kannaiah: What are your thoughts on the university-research-innovation ecosystem in India?
Rahul Mehta: The ecosystem has potential but needs improvement. India funds a large number of PhDs, which is a strength, but the focus needs to be on impactful research. Indian faculty also need to collaborate more within the country, not just internationally. It is about translating research into economic and social benefits.
Venkatesh Kannaiah: Where is the Mehta Family Foundation headed 10 years from now?
Rahul Mehta: I hope to expand our reach to support 10,000 students, up from 3,000 today, in cutting-edge fields like AI, robotics, global health, and sustainability.
Venkatesh Kannaiah: What are your three asks from the government?
Rahul Mehta: First, dramatically increase educational capacity to provide opportunities for more students. Second, promote research collaboration, both within India and globally, to drive innovation. Third, focus on translating research into economic prosperity and social impact by creating jobs.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


India.com
5 minutes ago
- India.com
No Entry For GM Crops, Says New Delhi; India-US Trade Talks Hit A Sacred Wall
New Delhi: Genetically modified (GM) crops will not be crossing India's borders anytime soon, no matter how urgently the United States knocks. As trade negotiations between New Delhi and Washington enter a crucial phase, insiders say one red line is not up for discussion. 'There are things that are not about negotiation. Some things are a matter of principle,' said a senior official close to the development. That principle, sources say, is GM corn and soy. While American negotiators have made agricultural access a central demand, pressing India for a wider entry gate for U.S. farm goods, New Delhi is not blinking, especially on GM imports. Over the years, the issue has mutated from a mere trade disagreement into a symbolic fight over sovereignty, food safety and grassroots politics. The United States Trade Representative (USTR) has repeatedly flagged India's restrictions on GM products, calling them 'non-tariff barriers'. But Indian authorities remain unmoved, largely because of the hardline stance taken by domestic groups closely aligned with the ruling establishment. Last month, the message from Sangh affiliates was if America insists on forcing GM crops into the Indian market, there may be no trade deal at all. Carried in Business Standard, that warning echoed the sentiments of influential groups such as the Bharatiya Kisan Sangh (BKS) and the Swadeshi Jagran Manch (SJM), which have long opposed agricultural concessions to Washington, particularly in sectors like dairy and GM crops. Their argument? Food security. The BKS has often warned that allowing U.S. crops into India, especially without clear labelling or transparency, could sabotage domestic farming ecosystems and compromise health safety standards. On the other hand, the SJM sees this as a direct attack on economic self-reliance. Meanwhile, the clock is ticking. U.S. officials have privately hinted at the urgency of the moment, pointing to a deadline set by President Donald Trump, who is seeking a revival of his trade agenda. Trump has marked August 1 as a red-letter day. If no interim deal is inked by then, India could be hit with reciprocal tariffs, potentially as high as 26 percent. Indian trade negotiators are not indifferent to that pressure. But according to officials involved in the process, the sixth round of talks will only happen in the second half of August after Trump's deadline expires. Any hope for a short-term resolution seems, at best, unrealistic. As one official put it, 'We are not looking at compromise in areas that touch the lives of millions.' In other words, GM corn is off the table. And perhaps, so is the deal, at least for now.


Hindustan Times
12 minutes ago
- Hindustan Times
‘One mission to watch Earth': ISRO-NASA's joint satellite NISAR set for July 30 launch
The Indian Space Research Organisation (ISRO) on Sunday stated that the upcoming launch of NISAR, the first joint Earth observation satellite by ISRO and NASA, will mark a key milestone in Earth observation technology. The NISAR mission's primary objectives are to study land & ice deformation, land ecosystems, and oceanic regions in areas of common interest to the US and Indian science communities.(X/@isro) NISAR will be launched from the Satish Dhawan Space Centre in Sriharikota, Andhra Pradesh, on July 30 at 17:40 IST. NISAR is the first mission of its kind, jointly developed by ISRO and NASA. It is an L- and S-band, global, microwave imaging mission, with the capability to acquire fully polarimetric and interferometric data, as per an official statement from ISRO. The unique dual-band Synthetic Aperture Radar of NISAR employs the advanced, novel SweepSAR technique, which provides high-resolution and large-swath imagery. NISAR will image the global land and ice-covered surfaces, including islands, sea-ice and selected oceans, every 12 days. The NISAR mission's primary objectives are to study land & ice deformation, land ecosystems, and oceanic regions in areas of common interest to the US and Indian science communities. Also read: Modi hails Shubhanshu Shukla's return to Earth as India's new Chandrayaan moment The joint mission will accomplish multiple tasks, including measuring the woody biomass and its changes, tracking changes in the extent of active crops, understanding the changes in wetlands' extent, and mapping Greenland & Antarctica's ice sheets and the dynamics of sea ice and mountain glaciers. As per the statement, it will also help characterise land surface deformation related to seismicity, volcanism, landslides, and subsidence & uplift associated with changes in subsurface aquifers, hydrocarbon reservoirs, etc. "One mission to watch Earth. #ISRO #NASA builds, Earth benefits. This marks a key milestone in Earth observation technology. Stay tuned as we bring you closer to the mission that watches our world," ISRO sais in a post on X. "The Spacecraft is built around ISRO's I-3K Structure. It carries two major Payloads viz., L & S- Band Synthetic Aperture Radar (SAR). The S-band Radar system, data handling & high-speed downlink system, the spacecraft and the launch system are developed by ISRO. The L-band Radar system, the high-speed downlink system, the Solid-State Recorder, the GPS receiver, and the 9 m Boom hoisting the 12m reflector are delivered by NASA. Further, ISRO takes care of the satellite commanding and operations; NASA will provide the orbit manoeuvre plan and RADAR operations plan. NISAR mission will be aided with ground station support from both ISRO and NASA for downloading of the acquired images, which, after the necessary processing, will be disseminated to the user community," the statement added. The data acquired through S-band and L-band SAR from a single platform will help scientists understand the changes happening to Planet Earth. The complex payloads and mainframe systems have been designed, developed, qualified and realised over a period of 8 to 10 years. "The S- Band SAR and L- Band SAR were independently developed, integrated and tested at ISRO and JPL/NASA respectively. The Integrated Radar Instrument Structure (IRIS), consisting of S - Band and L - Band SAR and other payload elements were intergrated and tested at JPL/NASA and delivered to ISRO," it stated. Mainframe satellite elements and payloads were assembled, integrated and tested at URSC/ISRO. The mission phases can be broadly classified into: Launch phase, Deployment Phase, Commissioning Phase and Science Phase. NISAR will be launched onboard the GSLV-F16 launch vehicle on July 30, 2025 from ISRO's Satish Dhawan Space Centre (SDSC), also referred to as Sriharikota High Altitude Range (SHAR), located in Sriharikota on the southeast coast of the Indian peninsula. It hosts a 12m dia large reflector which shall be deployed in-orbit 9m away from the satellite by a complex multistage deployable boom designed and developed by JPL/NASA. The first 90 days after launch will be dedicated to commissioning, or In-Orbit Checkout (IOC), the objective of which is to prepare the observatory for science operations. Commissioning is divided into sub-phases of initial checks and calibrations of mainframe elements followed by JPL engineering payload and instrument checkout. The science operations phase begins at the end of commissioning and extends till end of mission life. During this phase, the science orbit will be maintained via regular maneuvers, scheduled to avoid or minimize conflicts with science observations. Extensive calibration and validation (CalVal) activities will take place. The observation plan for both L and S-band instruments, along with engineering activities (e.g., maneuvers, parameter updates, etc.), will be generated pre-launch via frequent coordination between JPL and ISRO, the statement added.


Mint
an hour ago
- Mint
Lenskart receives shareholder nod to raise ₹2,150 crore via IPO: Report
Lenskart IPO: Peyush Bansal-led Indian eyewear company Lenskart has received the approval of its shareholder to raise ₹ 2,150 crore through a fresh issue of shares, reported MoneyControl, citing people aware of the development. According to news report, the company filed its corporate action development with the Ministry of Corporate Affairs' (MCA) Registrar of Companies (RoC), as per the data accessed by TheKredible. The proposal to raise money via an IPO was reportedly given the green light at the company's annual general meeting on 26 July 2025, said the report, adding, the eyewear company is expected to file its draft red herring prospectus (DRHP) with the capital markets regulator, the Securities and Exchange Board of India (Sebi), in the upcoming days. The overall IPO size is expected to be around $1 billion or ₹ 8,500 crore, which includes a secondary offer-for-sale (OFS) component by the existing investors, the report added. Earlier this month, Mint reported that the eyewear company's founder, Peyush Bansal, is looking to buy a 1.5-2% stake in the eyewear retailer worth about $150 million from existing investors ahead of its planned IPO. Peyush is buying small stakes from a bunch of investors. This is being negotiated at around $7-8 billion valuation. Existing investors like TR Capital, Chiratae, Softbank and Kedaara Capital are expected to sell their stake as part of the deal. Over the years, the company has raised $1.08 billion in funding across 19 rounds, including its latest Series I round for $18.2 million on 21 July 2023. It has received investments from various firms, including SoftBank Vision Fund, TPG, and Chiratae Ventures. Kotak Mahindra Capital, Axis Capital, Citi, Morgan Stanley, and Avendus Capital are the company-appointed book-runners for the IPO, which is soon expected to hit Dalal Street. The company was founded in 2010, and since then, it has emerged as one of the biggest players in the Indian eyewear industry. It has 2500 retail outlets across the nation and a presence globally, such as in Singapore and the United Arab Emirates (UAE).